Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Clinical & Experimental Metastasis
|
August 24, 2012
New tools for assessing the individual risk of metastasis in renal cell carcinoma
Edwin Herrmann, Carsten Weishaupt, Birgit Pöppelmann, et al.
Plos One
|
September 2, 2016
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
Martin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, et al.
Oncotargets and Therapy
|
March 24, 2017
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Ahmet Murat Aydin, Solomon L Woldu, Ryan C Hutchinson, et al.
International Journal of Molecular Sciences
|
February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
Martin Boegemann, Katrin Schlack, Stefan Thomes, et al.
The Canadian Journal of Urology
|
August 13, 2015
Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer
Laura-Maria Krabbe, Mary E Westerman, Vitaly Margulis, et al.
BMC Cancer
|
March 16, 2016
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
Phillip Mikah, Laura-Maria Krabbe, Okyaz Eminaga, et al.
The Journal of Urology
|
June 25, 2013
Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma
Bishoy A Gayed, Ramy F Youssef, Aditya Bagrodia, et al.
Urologic Oncology
|
July 20, 2017
Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy
Ryan Hutchinson, Nirmish Singla, Laura-Maria Krabbe, et al.
Urologic Oncology
|
December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary results
Bishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
World Journal of Urology
|
September 28, 2018
Molecular markers in bladder cancer
Francesco Soria, Laura-Maria Krabbe, Tilman Todenhöfer, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Clinical & Experimental Metastasis
|
August 24, 2012
New tools for assessing the individual risk of metastasis in renal cell carcinoma
Edwin Herrmann, Carsten Weishaupt, Birgit Pöppelmann, et al.
Plos One
|
September 2, 2016
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
Martin Boegemann, Katrin Schlack, Ann-Kathrin Fischer, et al.
Oncotargets and Therapy
|
March 24, 2017
Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Ahmet Murat Aydin, Solomon L Woldu, Ryan C Hutchinson, et al.
International Journal of Molecular Sciences
|
February 18, 2017
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
Martin Boegemann, Katrin Schlack, Stefan Thomes, et al.
The Canadian Journal of Urology
|
August 13, 2015
Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer
Laura-Maria Krabbe, Mary E Westerman, Vitaly Margulis, et al.
BMC Cancer
|
March 16, 2016
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
Phillip Mikah, Laura-Maria Krabbe, Okyaz Eminaga, et al.
The Journal of Urology
|
June 25, 2013
Prognostic role of cell cycle and proliferative biomarkers in patients with clear cell renal cell carcinoma
Bishoy A Gayed, Ramy F Youssef, Aditya Bagrodia, et al.
Urologic Oncology
|
July 20, 2017
Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy
Ryan Hutchinson, Nirmish Singla, Laura-Maria Krabbe, et al.
Urologic Oncology
|
December 3, 2014
Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary results
Bishoy A Gayed, Aditya Bagrodia, Mansi Gaitonde, et al.
World Journal of Urology
|
September 28, 2018
Molecular markers in bladder cancer
Francesco Soria, Laura-Maria Krabbe, Tilman Todenhöfer, et al.
Page
of 10